Literature DB >> 18971315

Regulation of hepatic cytochrome P450 expression in mice with intestinal or systemic infections of citrobacter rodentium.

Madhusudana R Chaluvadi1, Ryan D Kinloch, Beatrice A Nyagode, Terrilyn A Richardson, Malik J Raynor, Melanie Sherman, Leposava Antonovic, Henry W Strobel, Dirck L Dillehay, Edward T Morgan.   

Abstract

We reported previously that infection of C3H/HeOuJ (HeOu) mice with the murine intestinal pathogen Citrobacter rodentium caused a selective modulation of hepatic cytochrome P450 (P450) gene expression in the liver that was independent of the Toll-like receptor 4. However, HeOu mice are much more sensitive to the pathogenic effects of C. rodentium infection, and the P450 down-regulation was associated with significant morbidity in the animals. Here, we report that oral infection of C57BL/6 mice with C. rodentium, which produced only mild clinical signs and symptoms, produced very similar effects on hepatic P450 expression in this strain. As in HeOu mice, CYP4A mRNAs and proteins were among the most sensitive to down-regulation, whereas CYP4F18 was induced. CYP2D9 mRNA was also induced 8- to 9-fold in the C57BL/6 mice. The time course of P450 regulation followed that of colonic inflammation and bacterial colonization, peaking at 7 to 10 days after infection and returning to normal at 15 to 24 days as the infection resolved. These changes also correlated with the time course of significant elevations in the serum of the proinflammatory cytokines interleukin (IL)-6 and tumor necrosis factor-alpha, as well as of interferon-gamma and IL-2, with serum levels of IL-6 being markedly higher than those of the other cytokines. Intraperitoneal administration of C. rodentium produced a rapid down-regulation of P450 enzymes that was quantitatively and qualitatively different from that of oral infection, although CYP2D9 was induced in both models, suggesting that the effects of oral infection on the liver are not due to bacterial translocation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18971315      PMCID: PMC2631938          DOI: 10.1124/dmd.108.024240

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  37 in total

Review 1.  Animal models of inflammatory bowel disease.

Authors:  Abdo R Jurjus; Naim N Khoury; Jean-Marie Reimund
Journal:  J Pharmacol Toxicol Methods       Date:  2004 Sep-Oct       Impact factor: 1.950

2.  Enhanced survival of transgenic hepatocytes expressing hepatocyte growth factor in hepatocyte tissue engineering.

Authors:  T H Kim; H M Lee; H Utsonomiya; P Ma; R Langer; E V Schmidt; J P Vacanti
Journal:  Transplant Proc       Date:  1997 Feb-Mar       Impact factor: 1.066

3.  Nitric oxide-mediated inhibition of cytochrome P450 by interferon-gamma in human hepatocytes.

Authors:  M T Donato; M I Guillén; R Jover; J V Castell; M J Gómez-Lechón
Journal:  J Pharmacol Exp Ther       Date:  1997-04       Impact factor: 4.030

4.  The interleukin-2 receptor down-regulates the expression of cytochrome P450 in cultured rat hepatocytes.

Authors:  M Tinel; M A Robin; J Doostzadeh; M Maratrat; F Ballet; N Fardel; J el Kahwaji; P Beaune; M Daujat; G Labbe
Journal:  Gastroenterology       Date:  1995-11       Impact factor: 22.682

5.  Interferon down regulates the male-specific cytochrome P450IIIA2 in rat liver.

Authors:  P I Craig; I Mehta; M Murray; D McDonald; A Aström; P H van der Meide; G C Farrell
Journal:  Mol Pharmacol       Date:  1990-09       Impact factor: 4.436

6.  Administration of high doses of human recombinant interleukin-2 decreases the expression of several cytochromes P-450 in the rat.

Authors:  C Thal; J el Kahwaji; J Loeper; M Tinel; J Doostzadeh; G Labbe; J Leclaire; P Beaune; D Pessayre
Journal:  J Pharmacol Exp Ther       Date:  1994-01       Impact factor: 4.030

7.  Protective role of arginase in a mouse model of colitis.

Authors:  Alain P Gobert; Yulan Cheng; Mahmood Akhtar; Benjamin D Mersey; Darren R Blumberg; Raymond K Cross; Rupesh Chaturvedi; Cinthia B Drachenberg; Jean-Luc Boucher; Amy Hacker; Robert A Casero; Keith T Wilson
Journal:  J Immunol       Date:  2004-08-01       Impact factor: 5.422

8.  Down-regulation of multiple cytochrome P450 gene products by inflammatory mediators in vivo. Independence from the hypothalamo-pituitary axis.

Authors:  E T Morgan
Journal:  Biochem Pharmacol       Date:  1993-01-26       Impact factor: 5.858

9.  Suppression of the constitutive expression of cytochrome P-450 2C11 by cytokines and interferons in primary cultures of rat hepatocytes: comparison with induction of acute-phase genes and demonstration that CYP2C11 promoter sequences are involved in the suppressive response to interleukins 1 and 6.

Authors:  J Q Chen; A Ström; J A Gustafsson; E T Morgan
Journal:  Mol Pharmacol       Date:  1995-05       Impact factor: 4.436

10.  Attaching and effacing locus of a Citrobacter freundii biotype that causes transmissible murine colonic hyperplasia.

Authors:  D B Schauer; S Falkow
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

View more
  21 in total

Review 1.  Impact of infectious and inflammatory disease on cytochrome P450-mediated drug metabolism and pharmacokinetics.

Authors:  E T Morgan
Journal:  Clin Pharmacol Ther       Date:  2009-02-11       Impact factor: 6.875

2.  Selective role for tumor necrosis factor-α, but not interleukin-1 or Kupffer cells, in down-regulation of CYP3A11 and CYP3A25 in livers of mice infected with a noninvasive intestinal pathogen.

Authors:  Ryan D Kinloch; Choon-Myung Lee; Nico van Rooijen; Edward T Morgan
Journal:  Biochem Pharmacol       Date:  2011-05-06       Impact factor: 5.858

Review 3.  Drug disposition in pathophysiological conditions.

Authors:  Adarsh Gandhi; Bhagavatula Moorthy; Romi Ghose
Journal:  Curr Drug Metab       Date:  2012-11       Impact factor: 3.731

4.  Altered inflammatory responses to Citrobacter rodentium infection, but not bacterial lipopolysaccharide, in mice lacking the Cyp4a10 or Cyp4a14 genes.

Authors:  Beatrice A Nyagode; Ifor R Williams; Edward T Morgan
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

5.  CYP3A-dependent drug metabolism is reduced in bacterial inflammation in mice.

Authors:  A S Gandhi; T Guo; P Shah; B Moorthy; D S-L Chow; M Hu; R Ghose
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

6.  The cytochrome P450 genes of channel catfish: their involvement in disease defense responses as revealed by meta-analysis of RNA-Seq data sets.

Authors:  Jiaren Zhang; Jun Yao; Ruijia Wang; Yu Zhang; Shikai Liu; Luyang Sun; Yanliang Jiang; Jianbin Feng; Nannan Liu; David Nelson; Geoff Waldbieser; Zhanjiang Liu
Journal:  Biochim Biophys Acta       Date:  2014-04-27

7.  The effects of intestinal LPS exposure on inflammatory responses in a porcine enterohepatic co-culture system.

Authors:  Erzsebet Paszti-Gere; Gabor Matis; Orsolya Farkas; Anna Kulcsar; Orsolya Palocz; Gyorgy Csiko; Zsuzsanna Neogrady; Peter Galfi
Journal:  Inflammation       Date:  2014-02       Impact factor: 4.092

8.  Multivariate modeling identifies neutrophil- and Th17-related factors as differential serum biomarkers of chronic murine colitis.

Authors:  Megan E McBee; Yu Zeng; Nicola Parry; Cathryn R Nagler; Steven R Tannenbaum; David B Schauer
Journal:  PLoS One       Date:  2010-10-19       Impact factor: 3.240

9.  Selective modulation of hepatic cytochrome P450 and flavin monooxygenase 3 expression during citrobacter rodentium infection in severe combined immune-deficient mice.

Authors:  Beatrice A Nyagode; William J Watkins; Ryan D Kinloch; Edward T Morgan
Journal:  Drug Metab Dispos       Date:  2012-06-27       Impact factor: 3.922

10.  Hepatic flavin-containing monooxygenase gene regulation in different mouse inflammation models.

Authors:  Jun Zhang; Madhusudana R Chaluvadi; Rob Reddy; Meike S Motika; Terrilyn A Richardson; John R Cashman; Edward T Morgan
Journal:  Drug Metab Dispos       Date:  2008-12-16       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.